Credit Suisse Ag Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Credit Suisse Ag

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $271,740 - $335,485	500 Added 3.38%	15,300 $9.66 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $2.12 Million - $2.52 Million	-3,700 Reduced 20.0%	14,800 $8.96 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $661,920 - $781,956	1,400 Added 8.19%	18,500 $10.3 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $17.5 Million - $21.5 Million	-39,200 Reduced 69.63%	17,100 $8.09 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $9.66 Million - $12.3 Million	20,200 Added 55.96%	56,300 $27.2 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $10.7 Million - $12.9 Million	19,600 Added 118.79%	36,100 $20.2 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $16.5 Million - $24.3 Million	-49,100 Reduced 74.85%	16,500 $8.06 Million
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $2.84 Million - $3.31 Million	-10,400 Reduced 13.68%	65,600 $18.2 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $18.2 Million - $25.2 Million	60,700 Added 396.73%	76,000 $23.8 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $2.68 Million - $3.16 Million	-7,200 Reduced 32.0%	15,300 $6.28 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $5.04 Million - $6.05 Million	15,000 Added 200.0%	22,500 $8.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,500	7,500 $3.68 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.